Literature DB >> 29122915

Elevated lung clearance index in infants with cystic fibrosis shortly after birth.

Elisabeth Kieninger1,2, Sophie Yammine1,2, Insa Korten1,3, Pinelopi Anagnostopoulou1, Florian Singer1,4, Urs Frey3, Anne Mornand5, Maura Zanolari6, Isabelle Rochat7, Daniel Trachsel3, Dominik Mueller-Suter8, Alexander Moeller4, Carmen Casaulta1, Philipp Latzin9.   

Abstract

It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF). We assessed lung function shortly after birth in infants with CF diagnosed by newborn screening.We performed infant lung function measurements in a prospective cohort of infants with CF and healthy controls. We assessed lung clearance index (LCI), functional residual capacity (FRC) and tidal breathing parameters. The primary outcome was prevalence and severity of abnormal lung function (±1.64 z-scores) in CF.We enrolled 53 infants with CF (mean age 7.8 weeks) and 57 controls (mean age 5.2 weeks). Compared to controls, LCI and FRC were elevated (mean difference 0.30, 95% CI 0.02-0.60; p=0.034 and 14.5 mL, 95% CI 7.7-21.3 mL; p<0.001, respectively), while ratio of time to peak tidal expiratory flow to expiratory time was decreased in infants with CF. In 22 (41.5%) infants with CF, either LCI or FRC exceeded 1.64 z-scores; three infants had both elevated LCI and FRC.Shortly after birth, abnormal lung function is prevalent in CF infants. Ventilation inhomogeneity or hyperinflation may serve as noninvasive markers to monitor CF lung disease and specific treatment effects, and could thus be used as outcome parameters for future intervention studies in this age group.
Copyright ©ERS 2017.

Entities:  

Mesh:

Year:  2017        PMID: 29122915     DOI: 10.1183/13993003.00580-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

Review 1.  An Update on CFTR Modulators as New Therapies for Cystic Fibrosis.

Authors:  John A King; Anna-Louise Nichols; Sian Bentley; Siobhan B Carr; Jane C Davies
Journal:  Paediatr Drugs       Date:  2022-05-16       Impact factor: 3.022

2.  Nasal Resistome Development in Infants With Cystic Fibrosis in the First Year of Life.

Authors:  Aurélie Allemann; Julia G Kraemer; Insa Korten; Kathryn Ramsey; Carmen Casaulta; Daniel Wüthrich; Alban Ramette; Andrea Endimiani; Philipp Latzin; Markus Hilty
Journal:  Front Microbiol       Date:  2019-02-26       Impact factor: 5.640

Review 3.  Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis.

Authors:  Mirjam Stahl; Eva Steinke; Marcus A Mall
Journal:  Genes (Basel)       Date:  2021-05-25       Impact factor: 4.096

4.  Hyperinflation is associated with increased respiratory rate and is a more sensitive measure of cystic fibrosis lung disease during infancy compared to forced expiratory measures.

Authors:  Heather N Muston; James E Slaven; Christina Tiller; Charles Clem; Thomas W Ferkol; Sarath Ranganathan; Stephanie D Davis; Clement L Ren
Journal:  Pediatr Pulmonol       Date:  2021-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.